Publisher： Bentham Science Publishers
E-ISSN： 1873-4286|20|39|6191-6206
ISSN： 1381-6128
Source： Current Pharmaceutical Design, Vol.20, Iss.39, 2014-12, pp. : 6191-6206
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Adverse reactions to first-line antituberculosis drugs
Expert Opinion on Drug Safety, Vol. 5, Iss. 2, 2006-03 ,pp. :
Access to resources
Recommend
New Anti-Tuberculosis Drugs in Clinical Development: An Overview
Current Bioactive Compounds, Vol. 5, Iss. 2, 2009-06 ,pp. :
New Anti-Tuberculosis Drugs with Novel Mechanisms of Action
Current Medicinal Chemistry, Vol. 15, Iss. 19, 2008-01 ,pp. :
Current Bioactive Compounds, Vol. 2, Iss. 1, 2006-03 ,pp. :